Pain freedom at 2 hours in migraine after telcagepant 300mg

CNS Drugs

Volumn 25, Issue 3, 2011, Pages 269-270

  Tfelt Hansen, Peer ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Antimigraines, therapeutic use; Calcitonin gene related peptide receptor antagonists, therapeutic use; Migraine; Telcagepant, therapeutic use

Indexed keywords

PLACEBO; SUMATRIPTAN; TELCAGEPANT; ZOLMITRIPTAN;

ANALGESIA; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; HEADACHE; HUMAN; LETTER; MIGRAINE; PRIORITY JOURNAL;

AZEPINES; CLINICAL TRIALS AS TOPIC; HUMANS; IMIDAZOLES; MIGRAINE DISORDERS; PAIN; TREATMENT OUTCOME;

EID: 79951744258     PISSN: 11727047     EISSN: 11791934     Source Type: Journal    
DOI: 10.2165/11587770-000000000-00000     Document Type: Letter

References (10)

1. Durham PL, Vause CV. Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine. CNS Drugs 2010; 24: 539-48.
2. Ho TW, Mannix LK, Fan X, et al. Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology 2008; 70: 1304-12. (Pubitemid 351550355)
3. Ho TW, Ferrari MD, Dodick DW, et al. Efficacy and tol-erability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomized, placebocontrolled, parallel treatment trial. Lancet 2008; 372: 2115-23.
4. Connor KM, Shapiro RE, Diener H-C, et al. Randomized, controlled trial of telcagepant for the acute treatment of migraine. Neurology 2009; 73: 970-7.
5. Tfelt-Hansen P, Block G, Dahlof C; International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia 2000; 20: 765-86. (Pubitemid 32154559)
6. Lipton LB, Hammelsky SW, Dayno JM. What do patients with migraine want from acute migraine treatment? Headache 2002; 42 Suppl. 1: 3-9.
7. Edvinsson L, Ho TW. CGRP receptor antagonism and mi-graine. Neurotherapeutics 2010; 7: 164-75.
8. Tfelt-Hansen P. Excellent tolerability but relatively low ini-tial clinical efficacy of telcagepant in migraine. Headache 2011; 51: 118-23.
9. Ferrari MD, Goadsby PJ, Roon KI, et al. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia 2002; 22: 633-58 (Pubitemid 36609333)
10. Diener HC, Ferrari MD, Mansbach H; SNAP Database Study Group. Predicting the response to sumatriptan: the Sumatriptan Naratriptan Aggregate Patient Database. Neurology 2004; 63: 520-4 (Pubitemid 39031384)